Director's Dealing • Oct 22, 2025
Director's Dealing
Open in ViewerOpens in native device viewer
Observe Medical ASA: Mandatory notification of trade by primary insider
Oslo, 22 October 2025: Observe Medical ASA (the "Company") has been informed
that Jørgen Mann, CEO and primary insider in the Company, has today purchased
30,000 shares in the Company as further specified in the attached notification
form.
Following the purchase, Jørgen Mann holds 870,000 shares in the Company.
This information is subject to the disclosure requirements pursuant to article
19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian
Securities Trading Act.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.